TRAVIS DOBBS: Open Payments
NPI 1215461892 · TOCCOA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 57 payments from 18 companies in 2025. Trend: 2023 $1,288 · 2024 $958 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $176 |
| Indivior Inc. | 9 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $105 |
| Novo Nordisk Inc | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Eisai Inc. | 2 | $63 |
| PFIZER INC. | 4 | $61 |
| Lilly USA, LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Calliditas Therapeutics US Inc. | 1 | $36 |
Products named: SUBLOCADE, JARDIANCE, VRAYLAR, Kerendia, Leqembi, QULIPTA, ELIQUIS, Rybelsus.
Industry payments across GA — which companies pay providers there.
